Meaningful Physician Payment Reform in Oncology

2013 ◽  
Vol 9 (6S) ◽  
pp. 49s-53s ◽  
Author(s):  
Kavita K. Patel ◽  
Alexander J. Morin ◽  
Jeffrey L. Nadel ◽  
Mark B. McClellan

The authors describe various new models of physician payment that can serve as a foundation for a shift away from the current reimbursement system for cancer care to support better outcomes and avoid preventable costs, as well as how these reforms can be supported in a blended payment model that transitions away from but still contains elements of fee-for-service payments.

Author(s):  
Ray D. Page ◽  
Lee N. Newcomer ◽  
John D. Sprandio ◽  
Barbara L. McAneny

In recent years, the cost of providing quality cancer care has been subject to an epic escalation causing concerns on the verge of a health care crisis. Innovative patient-management models in oncology based on patient-centered medical home (PCMH) principles, coupled with alternative payments to traditional fee for service (FFS), such as bundled and episodes payment are now showing evidence of effectiveness. These efforts have the potential to bend the cost curve while also improving quality of care and patient satisfaction. However, going forward with FFS alternatives, there are several performance-based payment options with an array of financial risks and rewards. Most novel payment options convey a greater financial risk and accountability on the provider. Therefore, the oncology medical home (OMH) can be a way to mitigate some financial risks by sharing savings with the payer through better global care of the patient, proactively preventing complications, emergency department (ED) visits, and hospitalizations. However, much of the medical home infrastructure that is required to reduced total costs of cancer care comes as an added expense to the provider. As best-of-practice quality standards are being elucidated and refined, we are now at a juncture where payers, providers, policymakers, and other stakeholders should work in concert to expand and implement the OMH framework into the variety of oncology practice environments to better equip them to assimilate into the new payment reform configurations of the future.


2018 ◽  
Vol 149 (2) ◽  
pp. 232-240 ◽  
Author(s):  
Emily M. Ko ◽  
Laura J. Havrilesky ◽  
Ronald D. Alvarez ◽  
Oliver Zivanovic ◽  
Leslie R. Boyd ◽  
...  

JAMA ◽  
1994 ◽  
Vol 272 (24) ◽  
pp. 1890
Author(s):  
Bruce C. Vladeċk

1989 ◽  
Vol 8 (4) ◽  
pp. 76-83 ◽  
Author(s):  
Victor G. Rodwin

2002 ◽  
Vol 12 (4) ◽  
pp. 1-4 ◽  
Author(s):  
Alan M. Scarrow

Payment for physician services in the United States is directly tied to the payment system implemented in the Medicare system. The use of a code to categorize medical and surgical services, as well as a relative value system to assess physician services and reimburse them accordingly, is now well established. In light of this, it is important for physicians to possess knowledge of how this coding and reimbursement system was established, how it is updated, what means are available to modify it, and how it is used in practice. The author addresses these issues, offering a primer for the neurosurgeon on the Medicare system as it relates to physician payment.


2021 ◽  
pp. OP.21.00330
Author(s):  
Constantine A. Mantz ◽  
Nikhil G. Thaker ◽  
Praveen Pendyala ◽  
Anne Hubbard ◽  
Thomas J. Eichler ◽  
...  

PURPOSE: The Radiation Oncology Alternative Payment Model (APM) is a Medicare demonstration project that will test whether prospective bundled payments to a randomly selected group of physician practices, hospital outpatient departments, and freestanding radiation therapy centers reduce overall expenditures while preserving or enhancing the quality of care for beneficiaries. The Model follows a complicated pricing methodology that blends historical reimbursements for a defined set of services made to professional and technical providers to create a weighted payment average for each of 16 cancer types. These averages are then adjusted by various factors to determine APM payments specific to each participating provider. METHODS: This impact study segregates APM participants into rural and urban groups and analyzes the effect of the Radiation Oncology Alternative Payment Model on their fee-for-service reimbursements. RESULTS: The main findings of this study are (1) the greater net-negative revenue impact on rural facilities versus urban facilities that would have participated in the Model this year and (2) the relative lack of high-value treatment services (ie, stereotactic radiotherapy and brachytherapy) delivered by rural facilities that exacerbates their negative impact. CONCLUSION: As such, rural providers participating in the Model in its current form may face greater risk to their economic viability and greater difficulty in funding technology improvements necessary for the achievement of high-quality care compared with their urban counterparts.


1989 ◽  
Vol 111 (5) ◽  
pp. 351
Author(s):  
Robert A. Berenson

1987 ◽  
Vol 107 (6) ◽  
pp. 929
Author(s):  
ROBERT A. BERENSON

Sign in / Sign up

Export Citation Format

Share Document